Biblography
Our searchable, sortable bibliography is the most comprehensive listing of articles, posters, abstracts, and CME programs on biologic therapy in psoriasis available on the Web. Links to these documents are provided where possible.
Deeva I, Mariani S, De Luca C, et al.. Wide-spectrum profile of inflammatory mediators in the plasma and scales of patients with psoriatic disease.Cytokine. 2010 Feb;49(2):163-70.
Date Published: February 2010
Keywords: View Abstract
Takahashi H, Takahashi I, Honma M, et al.. Prevalence of metabolic syndrome in Japanese psoriasis patients.J Dermatol Sci. 2010 Feb;57(2):143-4.
Date Published: February 2010
Keywords: View Abstract
Van den Bosch F, Manger B, Goupille P, et al.. Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions.Ann Rheum Dis. 2010 Feb;69(2):394-9.
Date Published: February 2010
Keywords: View Abstract
Balci A, Balci DD, Yonden Z, et al.. Increased amount of visceral fat in patients with psoriasis contributes to metabolic syndrome.Dermatology. 2010;220(1):32-7.
Date Published: January 2010
Keywords: View Abstract
Gerdes S, Zahl VA, Weichenthal M, et al.. Smoking and alcohol intake in severely affected patients with psoriasis in Germany.Dermatology. 2010;220(1):38-43.
Date Published: January 2010
Keywords: View Abstract
Mease PJ, Signorovitch J, Yu AP, et al.. Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trials.Dermatology. 2010;220(1):1-7.
Date Published: January 2010
Keywords: View Abstract
Menter A, Korman NJ, Elmets CA, et al.. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy.J Am Acad Dermatol. 2010 Jan;62(1):114-35.
Date Published: January 2010
Keywords: View Abstract
Puig L, Barco D, Alomar A. Treatment of psoriasis with anti-TNF drugs during pregnancy: case report and review of the literature.Dermatology. 2010;220(1):71-6.
Date Published: January 2010
Keywords: View Abstract
Schäfer I, Hacker J, Rustenbach SJ, et al.. Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment.Eur J Dermatol. 2010 Jan-Feb;20(1):62-7.
Date Published: January 2010
Keywords: View Abstract
Steinman L. Mixed results with modulation of TH-17 cells in human autoimmune diseases.Nat Immunol. 2010 Jan;11(1):41-4.
Date Published: January 2010
Keywords: View Abstract
Zhou H, Hu C, Zhu Y, et al.. Population-based exposure-efficacy modeling of ustekinumab in patients with moderate to severe plaque psoriasis.J Clin Pharmacol. 2010 Mar;50(3):257-67.
Date Published: January 2010
Keywords: View Abstract
No authors listed.. Psoriasis. Inflammatory disorder may be more than skin deep.Mayo Clin Womens Healthsource. 2009 Dec;13(12):4-5.
Date Published: December 2009
Keywords: View Abstract
No authors listed.. Childhood psoriasis: often favorable outcome.Prescrire Int. 2009 Dec;18(104):275.
Date Published: December 2009
Keywords: View Abstract
Bergman R, Ramon M, Wildbaum G, et al.. Psoriasis patients generate increased serum levels of autoantibodies to tumor necrosis factor-alpha and interferon-alpha.J Dermatol Sci. 2009 Dec;56(3):163-7.
Date Published: December 2009
Keywords: View Abstract
Birkenfeld S, Dreiher J, Weitzman D, et al.. Coeliac disease associated with psoriasis.Br J Dermatol. 2009 Dec;161(6):1331-4.
Date Published: December 2009
Keywords: View Abstract
Burmester GR, Mease P, Dijkmans BA, et al.. Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases.Ann Rheum Dis. 2009 Dec;68(12):1863-9.
Date Published: December 2009
Keywords: View Abstract
Coimbra S, Oliveira H, Reis F, et al.. C-reactive protein and leucocyte activation in psoriasis vulgaris according to severity and therapy.J Eur Acad Dermatol Venereol. 2009 Dec 11. [Epub ahead of print]
Date Published: December 2009
Keywords: View Abstract
Conaghan PG, Coates LC. Improving recognition of psoriatic arthritis.Practitioner. 2009 Dec;253(1724):15-8, 2-3.
Date Published: December 2009
Keywords: View Abstract
Dawe RS. Comparing narrowband ultraviolet B treatment regimens for psoriasis.Br J Dermatol. 2009 Dec;161(6):1215-6.
Date Published: December 2009
Keywords: View Abstract
Duffin KC, Freeny IC, Schrodi SJ, et al.. Association between IL13 polymorphisms and psoriatic arthritis is modified by smoking.J Invest Dermatol. 2009 Dec;129(12):2777-83.
Date Published: December 2009
Keywords: View Abstract
Elliott M, Benson J, Blank M, et al.. Ustekinumab: lessons learned from targeting interleukin-12/23p40 in immune-mediated diseases.Ann N Y Acad Sci. 2009 Dec;1182():97-110.
Date Published: December 2009
Keywords: View Abstract
Eyerich S, Eyerich K, Pennino D, et al.. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling.J Clin Invest. 2009 Dec;119(12):3573-85.
Date Published: December 2009
Keywords: View Abstract
Foley P, Freeman M, Gebauer K, et al.. Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis: results from an Australian expanded access program.Int J Dermatol. 2009 Dec;48(12):1376-84.
Date Published: December 2009
Keywords: View Abstract
Frankel AJ, Van Voorhees AS, Hsu S, et al.. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation.J Am Acad Dermatol. 2009 Dec;61(6):1044-55.
Date Published: December 2009
Keywords: View Abstract
Frankel AJ, Van Voorhees AS, Hsu S, et al.. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation.J Am Acad Dermatol. 2009 Dec;61(6):1044-55.
Date Published: December 2009
Keywords: View Abstract
REGISTER NOW
